BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32266558)

  • 1. 18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
    Lazzarotto D; Facchin G; Candoni A; Fanin R
    Mycopathologia; 2020 Jun; 185(3):597-598. PubMed ID: 32266558
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated Scedosporium Invasive Fungal Infection in Critically ill Newly Diagnosed Acute Myeloid Leukemia Patient Complicated with Cerebritis.
    Saillard C; Bisbal M; Avenin M; Lehmann P; Sannini A; Chow-Chine L; Servan L; Gonzalez F; d'Incan E; Vey N; Mokart D
    Mycopathologia; 2023 Dec; 188(6):1099-1101. PubMed ID: 37815689
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
    Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
    Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic veno-occlusive disease during isavuconazole administration.
    Mesini A; Cangemi G; Palmisani E; Dufour C; Castagnola E
    J Chemother; 2018 Feb; 30(1):63-64. PubMed ID: 29278102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].
    Garcia-Vidal C
    Rev Iberoam Micol; 2018; 35(4):192-197. PubMed ID: 30455108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole treatment of a patient with disseminated mucormycosis.
    Peixoto D; Gagne LS; Hammond SP; Gilmore ET; Joyce AC; Soiffer RJ; Marty FM
    J Clin Microbiol; 2014 Mar; 52(3):1016-9. PubMed ID: 24403304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.
    Cummins KC; Cheng MP; Kubiak DW; Davids MS; Marty FM; Issa NC
    Leuk Lymphoma; 2019 Feb; 60(2):527-530. PubMed ID: 30037292
    [No Abstract]   [Full Text] [Related]  

  • 8. Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.
    Rausch CR; DiPippo AJ; Bose P; Kontoyiannis DP
    Clin Infect Dis; 2018 Oct; 67(10):1610-1613. PubMed ID: 29771293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?
    Fung M; Schwartz BS; Doernberg SB; Langelier C; Lo M; Graff L; Tan M; Logan AC; Chin-Hong P; Babik JM
    Clin Infect Dis; 2018 Sep; 67(7):1142-1143. PubMed ID: 29617983
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
    Vincent AL; Cabrero JE; Greene JN; Sandin RL
    Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
    [No Abstract]   [Full Text] [Related]  

  • 11. Invasive Fungal Disease, Isavuconazole Treatment Failure, and Death in Acute Myeloid Leukemia Patients.
    Bellanger AP; Berceanu A; Scherer E; Desbrosses Y; Daguindau E; Rocchi S; Millon L
    Emerg Infect Dis; 2019 Sep; 25(9):1778-1779. PubMed ID: 31441760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
    Cornely OA; Böhme A; Schmitt-Hoffmann A; Ullmann AJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2078-85. PubMed ID: 25624327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
    Stavropoulou E; Coste AT; Beigelman-Aubry C; Letovanec I; Spertini O; Lovis A; Krueger T; Burger R; Bochud PY; Lamoth F
    BMC Infect Dis; 2020 Jul; 20(1):527. PubMed ID: 32698804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infection caused by Blastobotrys mokoenaii in an immunocompromised patient with acute myeloid leukemia: A case report.
    Shiomi I; Makuuchi Y; Noura I; Kakuno S; Niki M; Kaimi Y; Ido K; Sakatoku K; Kuno M; Takakuwa T; Okamura H; Nishimoto M; Nakashima Y; Nakamae M; Kakeya H; Kohashi K; Hino M; Nakamae H
    J Infect Chemother; 2024 Jun; 30(6):557-561. PubMed ID: 38092335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
    Pilmis B; Lortholary O; Lanternier FL
    Rev Prat; 2015 Dec; 65(10):1334-9. PubMed ID: 26979038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature.
    Di Franco G; Tagliaferri E; Pieroni E; Benedetti E; Guadagni S; Palmeri M; Furbetta N; Campani D; Di Candio G; Petrini M; Mosca F; Morelli L
    Infection; 2018 Jun; 46(3):317-324. PubMed ID: 29357049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
    Wong GC; Abdul Halim NA; Tan BH
    Clin Infect Dis; 2015 Oct; 61(8):1351-2. PubMed ID: 26139846
    [No Abstract]   [Full Text] [Related]  

  • 18. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
    Kim MS; Lee HM; Sung HS; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Int J Dermatol; 2012 May; 51(5):621-3. PubMed ID: 21790547
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections.
    Hot A; Maunoury C; Poiree S; Lanternier F; Viard JP; Loulergue P; Coignard H; Bougnoux ME; Suarez F; Rubio MT; Mahlaoui N; Dupont B; Lecuit M; Faraggi M; Lortholary O
    Clin Microbiol Infect; 2011 Mar; 17(3):409-17. PubMed ID: 20636432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug development challenges and strategies to address emerging and resistant fungal pathogens.
    McCarthy MW; Walsh TJ
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):577-584. PubMed ID: 28480775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.